| A12 | Human monoclonal antibody against IGF-IR |
| AK | Actinic keratosis |
| Ang1/2 | Angiopoietin 1/2 |
| BCC | Basal cell carcinoma/Basalioma |
| CD31 | Cluster of differentiation 31 = Platelet endothelial cell adhesion molecule |
| CD34 | Cluster of differentiation 34 |
| CD105 | Cluster of differentiation 105 = Endoglin |
| CT | Computed tomography |
| cSCC | Spinocellular carcinoma of the skin/squamous cell carcinoma/spinalioma |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| HIF-1α | Hypoxia-inducible factor 1α |
| HPV | Human papillomavirus |
| IGF-IR | Insulin-like growth factor 1 receptor |
| IgG1 | Immunoglobulin G1 |
| Ki67 | Antigen Ki67 |
| LRIG2 | leucine-rich repeats and immunoglobulin-like domains 2 |
| mRNA | Messenger ribonucleic acid |
| NF-κB | Nuclear factor kappa B |
| p21 | CDK-Inhibitor 1 = cyclin-dependent kinase inhibitor 1 |
| PD1 | Programmed cell death protein 1 |
| RAS | Rat sarcoma |
| RDBE | recessive dystrophic epidermolysis bullosa |
| RNA | Ribonucleic acid |
| αSMA | Smooth muscle actin |
| TGFβ | Transforming growth factor β |
| TP53/P53 | Tumorprotein p53 |
| TPA | 12-O-tetradecanoylphorbol-13-acetate |
| TRAF6 | Tumor necrosis factor receptor-associated factor 6 |
| UV | Ultraviolet |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptor |